The data, which suggest that one shot helps prevent cancer, came from a clinical trial run by the National Cancer Institute. Also in vaccine news: a tuberculosis vaccine trial; vaccine policy at the ...

A vaccine that blocks infection with the human papillomavirus has helped to lower cervical cancer rates. Researchers want to ...

Developed by Molbio Diagnostics — which is known for providing low-cost tests for the country’s TB programme — the molecular ...

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...

A small case-control study found potential molecular evidence that links human papillomavirus (HPV) to thyroid eye disease ...

“Unfortunately, Alabama is significantly higher in both cervical cancer incidence and mortality rates when compared to the U.S. Fortunately, HPV vaccination can eliminate the vast majority of cervical ...

Cancers caused by the human papillomavirus (HPV) cause result in 6,100 deaths a year in America. HPV vaccination could ...

On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against ...

HPV is a leading cause of cervical cancer in women, but 50% of people who develop the cancer are never tested. A self-collection test could help.

Project ECHO HPV Vaccination Series receives support in honor of UNR Med Alumnus John M. Erickson, M.D.

Under direction of Health Secretary Robert F. Kennedy Jr., the CDC is considering changes to its recommendations on vaccines ...

The findings from Fred Hutch Cancer Center suggest next step of exploring whether one dose of the vaccine is enough.